Postexposure Efficacy of Recombinant Vesicular Stomatitis Virus Vectors Against High and Low Doses of Marburg Virus Variant Angola in Nonhuman Primates

por Woolsey, Courtney, Geisbert, Joan B, Matassov, Demetrius, Agans, Krystle N, Borisevich, Viktoriya, Cross, Robert W, Deer, Daniel J, Fenton, Karla A, Eldridge, John H, Mire, Chad E, Geisbert, Thomas W
Publicado 2018

Single dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virus

por Mire, Chad E., Matassov, Demetrius, Geisbert, Joan B., Latham, Theresa E., Agans, Krystle N., Xu, Rong, Ota-Setlik, Ayuko, Egan, Michael A., Fenton, Karla A., Clarke, David K., Eldridge, John H., Geisbert, Thomas W.
Publicado 2015

A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challenge

por Woolsey, Courtney, Cross, Robert W., Agans, Krystle N., Borisevich, Viktoriya, Deer, Daniel J., Geisbert, Joan B., Gerardi, Cheryl, Latham, Theresa E., Fenton, Karla A., Egan, Michael A., Eldridge, John H., Geisbert, Thomas W., Matassov, Demetrius
Publicado 2022

Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola Virus

por Matassov, Demetrius, Marzi, Andrea, Latham, Terri, Xu, Rong, Ota-Setlik, Ayuko, Feldmann, Friederike, Geisbert, Joan B., Mire, Chad E., Hamm, Stefan, Nowak, Becky, Egan, Michael A., Geisbert, Thomas W., Eldridge, John H., Feldmann, Heinz, Clarke, David K.
Publicado 2015

Immune correlates of postexposure vaccine protection against Marburg virus

por Woolsey, Courtney, Jankeel, Allen, Matassov, Demetrius, Geisbert, Joan B., Agans, Krystle N., Borisevich, Viktoriya, Cross, Robert W., Deer, Daniel J., Fenton, Karla A., Latham, Theresa E., Gerardi, Cheryl S., Mire, Chad E., Eldridge, John H., Messaoudi, Ilhem, Geisbert, Thomas W.
Publicado 2020

Preclinical Development of Oncolytic Immunovirotherapy for Treatment of HPV(POS) Cancers

por Suksanpaisan, Lukkana, Xu, Rong, Tesfay, Mulu Z., Bomidi, Carolyn, Hamm, Stefan, Vandergaast, Rianna, Jenks, Nathan, Steele, Michael B., Ota-Setlik, Ayuko, Akhtar, Hinna, Luckay, Amara, Nowak, Rebecca, Peng, Kah Whye, Eldridge, John H., Clarke, David K., Russell, Stephen J., Diaz, Rosa Maria
Publicado 2018

First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090)

por Fuchs, Jonathan D., Frank, Ian, Elizaga, Marnie L., Allen, Mary, Frahm, Nicole, Kochar, Nidhi, Li, Sue, Edupuganti, Srilatha, Kalams, Spyros A., Tomaras, Georgia D., Sheets, Rebecca, Pensiero, Michael, Tremblay, Marc A., Higgins, Terry J., Latham, Theresa, Egan, Michael A., Clarke, David K., Eldridge, John H.
Publicado 2015

A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime-Boost Combinations w...

por Mpendo, Juliet, Mutua, Gaudensia, Nyombayire, Julien, Ingabire, Rosine, Nanvubya, Annet, Anzala, Omu, Karita, Etienne, Hayes, Peter, Kopycinski, Jakub, Dally, Len, Hannaman, Drew, Egan, Michael A., Eldridge, John H., Syvertsen, Kristen, Lehrman, Jennifer, Rasmussen, Beth, Gilmour, Jill, Cox, Josephine H., Fast, Patricia E., Schmidt, Claudia
Publicado 2015

Safety and tolerability of HIV-1 multiantigen pDNA vaccine given with IL-12 plasmid DNA via electroporation, boosted with a recombinant vesicular stomatitis virus HIV Gag vaccine i...

por Elizaga, Marnie L., Li, Shuying S., Kochar, Nidhi K., Wilson, Gregory J., Allen, Mary A., Tieu, Hong Van N., Frank, Ian, Sobieszczyk, Magdalena E., Cohen, Kristen W., Sanchez, Brittany, Latham, Theresa E., Clarke, David K., Egan, Michael A., Eldridge, John H., Hannaman, Drew, Xu, Rong, Ota-Setlik, Ayuko, McElrath, M. Juliana, Hay, Christine Mhorag
Publicado 2018